NPI: 1295700219 · SELMA, CA 93662 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/22/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/22/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 16,596 | $506K |
| 2019 | 10,423 | $183K |
| 2020 | 8,531 | $149K |
| 2021 | 6,048 | $248K |
| 2022 | 7,276 | $383K |
| 2023 | 12,283 | $461K |
| 2024 | 11,186 | $447K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 50,110 | 4,125 | $2.32M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 5,717 | 411 | $26K |
| A4657 | Syringe, with or without needle, each | 4,984 | 1,194 | $18K |
| 0250 | 1,857 | 140 | $7K | |
| J1756 | Injection, iron sucrose, 1 mg | 3,158 | 979 | $5K |
| J1270 | Injection, doxercalciferol, 1 mcg | 3,212 | 289 | $2K |
| 83970 | 436 | 419 | $935.94 | |
| 82728 | 173 | 169 | $274.31 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 741 | 500 | $208.52 |
| 83550 | 115 | 111 | $171.41 | |
| 83540 | 158 | 155 | $130.38 | |
| 85045 | 467 | 331 | $90.69 | |
| 85041 | 428 | 404 | $7.20 | |
| 85048 | 428 | 401 | $6.15 | |
| 90674 | 77 | 73 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 67 | 42 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 146 | 137 | $0.00 |
| 90747 | 12 | 12 | $0.00 | |
| 82607 | 13 | 13 | $0.00 | |
| 90662 | 17 | 17 | $0.00 | |
| 82108 | 27 | 27 | $0.00 |